FUNDAMENTALS · Fundamentals · AE Consumer Defensive

Softcare (2698) Fundamentals 2026 — P/E 19.5x, Revenue Analysis | SniperIQ

Softcare (2698) is a AE-listed Consumer Defensive company in Household & Personal Products with a market capitalization of HK

9.6B, trading at HK
1.60 on the HKSE. This SniperIQ fundamentals page covers Softcare's valuation (P/E 19.5x, P/B 3.7x), profitability (net margin 21.4%), revenue (¥4.0B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapHK
9.6B
P/E (TTM)19.5x
Net Margin21.4%
Revenue (FY25)¥4.0B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Softcare's market cap?

Softcare (2698) has a market capitalization of approximately HK

9.6B, trading at HK
1.60 on the HKSE. Market cap moves with the live share price.

What is Softcare's P/E ratio?

Softcare's trailing twelve-month P/E ratio is 19.5x, with a price-to-book (P/B) of 3.7x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.

How profitable is Softcare?

Softcare runs a net profit margin of 21.4%, a gross margin of 35.9%, and an operating margin of 25.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Softcare generate?

Softcare reported revenue of ¥4.0B for fiscal year 2025, with net income of ¥848M and earnings per share (EPS) of 1.4. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Softcare pay a dividend?

Softcare offers a trailing dividend yield of about 2.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Softcare financially healthy?

Softcare carries a debt-to-equity ratio of 0.03x and a current ratio of 5.69x, with a market beta of -0.23. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Softcare a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Softcare (2698) the key facts are: market cap HK

9.6B, P/E 19.5x, revenue ¥4.0B, 52-week range 23.86-36.8. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.

Track Softcare's full fundamentals live

Get Softcare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Nichimo (8091) fundamentals · Miyoshi Oil & Fat (4404) fundamentals · General Mills (GIS) fundamentals · AXYZ (1381) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons